XML 17 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Investments
9 Months Ended
Sep. 30, 2019
Investments [Abstract]  
Investments

2.     INVESTMENTS



The Company’s investments are primarily composed of fixed income debt securities and common and preferred stock equity securities. We carry our equity securities at fair value and categorize all our fixed maturity debt securities as available-for-sale (AFS), which are carried at fair value. When available, quoted market prices are obtained to determine fair value for the Company’s investments. If a quoted market price is not available, fair value is estimated using a secondary pricing source or using quoted market prices of similar securities. The Company has no investment securities for which fair value is determined using Level 3 inputs as defined in Note 3 – Fair Value Disclosures. Realized gains and losses on disposition of investments are based on specific identification of the investments sold on the settlement date, which does not differ significantly from trade date accounting.



Available-for-Sale Fixed Maturity and Equity Securities



The following tables are a summary of the proceeds from sales, maturities, and calls of available-for-sale fixed maturity and equity securities and the related gross realized gains and losses.







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

For the Three-Months Ended September 30,



 

 

 

 

 

 

 

 

 

 

Net Realized



 

Proceeds

 

Gains

 

Losses

 

Gains (Losses)

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

5,771,988 

 

$

99,445 

 

$

(10,183)

 

$

89,262 

Common stocks

 

 

1,320,803 

 

 

185,319 

 

 

(133,100)

 

 

52,219 

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

3,512,293 

 

$

45,130 

 

$

(30,165)

 

$

14,965 

Common stocks

 

 

533,388 

 

 

61,330 

 

 

(60,591)

 

 

739 

Preferred stocks

 

 

66,000 

 

 

 —

 

 

(675)

 

 

(675)













 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

For the Nine-Months Ended September 30,



 

 

 

 

 

 

 

 

 

 

Net Realized



 

Proceeds

 

Gains

 

Losses

 

Gains

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

19,522,461 

 

$

264,737 

 

$

(26,332)

 

$

238,405 

Common stocks

 

 

5,998,276 

 

 

960,420 

 

 

(457,702)

 

 

502,718 

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities

 

$

10,181,569 

 

$

97,917 

 

$

(56,280)

 

$

41,637 

Common stocks

 

 

9,367,763 

 

 

1,164,192 

 

 

(122,833)

 

 

1,041,359 

Preferred stocks

 

 

3,927,722 

 

 

86,862 

 

 

(82,629)

 

 

4,233 



The amortized cost and estimated fair value of fixed income securities at September 30, 2019, by contractual maturity, are shown as follows:







 

 

 

 

 

 



 

 

 

 

 

 



 

Amortized Cost

 

Fair Value

Due in one year or less

 

$

3,706,721 

 

$

3,724,171 

Due after one year through five years

 

 

20,527,932 

 

 

21,357,177 

Due after five years through 10 years

 

 

14,516,310 

 

 

15,749,391 

Due after 10 years

 

 

13,833,858 

 

 

15,217,981 

Asset and mortgage backed securities without a specific due date

 

 

36,272,187 

 

 

36,869,747 

Total fixed maturity securities

 

$

88,857,008 

 

$

92,918,467 



Expected maturities may differ from contractual maturities due to call provisions on some existing securities.

The following table is a schedule of cost or amortized cost and estimated fair values of investments in securities classified as available for sale at September 30, 2019 and December 31, 2018:  









 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Cost or

 

 

 

 

Gross Unrealized



 

Amortized Cost

 

Fair Value

 

Gains

 

Losses

2019

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

$

1,349,993 

 

$

1,347,742 

 

$

761 

 

$

(3,012)

MBS/ABS/CMBS

 

 

36,272,188 

 

 

36,869,747 

 

 

655,901 

 

 

(58,342)

Corporate

 

 

40,936,728 

 

 

43,509,784 

 

 

2,576,595 

 

 

(3,539)

Municipal

 

 

10,298,099 

 

 

11,191,194 

 

 

893,095 

 

 

 —

Total AFS securities

 

$

88,857,008 

 

$

92,918,467 

 

$

4,126,352 

 

$

(64,893)







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Cost or

 

 

 

 

Gross Unrealized



 

Amortized Cost

 

Fair Value

 

Gains

 

Losses

2018

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

$

1,348,575 

 

$

1,328,925 

 

$

 —

 

$

(19,650)

MBS/ABS/CMBS

 

 

34,372,133 

 

 

33,799,024 

 

 

33,955 

 

 

(607,064)

Corporate

 

 

37,383,903 

 

 

37,366,690 

 

 

376,029 

 

 

(393,242)

Municipal

 

 

16,148,295 

 

 

16,486,520 

 

 

398,569 

 

 

(60,344)

Total fixed maturity securities

 

 

89,252,906 

 

 

88,981,159 

 

 

808,553 

 

 

(1,080,300)

Equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Common stocks

 

 

13,572,713 

 

 

11,843,223 

 

 

406,812 

 

 

(2,136,302)

Total equity securities1

 

 

13,572,713 

 

 

11,843,223 

 

 

406,812 

 

 

(2,136,302)

Total AFS securities

 

$

102,825,619 

 

$

100,824,382 

 

$

1,215,365 

 

$

(3,216,602)



1Effective January 1, 2019, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale. Prior periods have not been recast to conform to the current presentation.



All the Company’s collateralized securities carry an average credit rating of AA+ by one or more major rating agencies and continue to pay according to contractual terms. Included within MBS/ABS/CMBS, as defined in Note 3 – Fair Value Disclosures, are residential mortgage backed securities with fair values of $13,386,554 and $13,696,585 and commercial mortgage backed securities of $12,545,859 and $10,126,352 at September 30, 2019 and December 31, 2018, respectively.

ANALYSIS



The following tables are also used as part of the impairment analysis and displays the total value of securities that were in an unrealized loss position as of September 30, 2019, and December 31, 2018. The tables segregate the securities based on type, noting the fair value, cost (or amortized cost), and unrealized loss on each category of investment as well as in total. The table further classifies the securities based on the length of time they have been in an unrealized loss position.







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

September 30, 2019



 

 

 

 

12 Months

 

 

 



 

< 12 Months

 

& Greater

 

Total

Fixed Maturity Securities:

 

 

 

 

 

 

 

 

 

U.S. Treasury

 

 

 

 

 

 

 

 

 

Fair value

 

$

 —

 

$

1,246,820 

 

$

1,246,820 

Cost or amortized cost

 

 

 —

 

 

1,249,832 

 

 

1,249,832 

Unrealized loss

 

 

 —

 

 

(3,012)

 

 

(3,012)

MBS/ABS/CMBS

 

 

 

 

 

 

 

 

 

Fair value

 

 

4,940,313 

 

 

4,706,813 

 

 

9,647,126 

Cost or amortized cost

 

 

4,947,399 

 

 

4,758,069 

 

 

9,705,468 

Unrealized loss

 

 

(7,086)

 

 

(51,256)

 

 

(58,342)

Corporate

 

 

 

 

 

 

 

 

 

Fair value

 

 

1,005,982 

 

 

 —

 

 

1,005,982 

Cost or amortized cost

 

 

1,009,521 

 

 

 —

 

 

1,009,521 

Unrealized loss

 

 

(3,539)

 

 

 —

 

 

(3,539)

Total debt securities available for sale

 

 

 

 

 

 

 

 

 

Fair value

 

 

5,946,295 

 

 

5,953,633 

 

 

11,899,928 

Cost or amortized cost

 

 

5,956,920 

 

 

6,007,901 

 

 

11,964,821 

Unrealized loss

 

 

(10,625)

 

 

(54,268)

 

 

(64,893)







 

 

 

 

 

 

 

 

 



 

December 31, 2018



 

 

 

 

12 Months

 

 

 



 

< 12 Months

 

& Greater

 

Total

U.S. Treasury

 

 

 

 

 

 

 

 

 

Fair value

 

$

 —

 

$

1,328,925 

 

$

1,328,925 

Cost or amortized cost

 

 

 —

 

 

1,348,575 

 

 

1,348,575 

Unrealized loss

 

 

 —

 

 

(19,650)

 

 

(19,650)

MBS/ABS/CMBS

 

 

 

 

 

 

 

 

 

Fair value

 

 

16,890,857 

 

 

11,956,493 

 

 

28,847,350 

Cost or amortized cost

 

 

17,039,357 

 

 

12,415,057 

 

 

29,454,414 

Unrealized loss

 

 

(148,500)

 

 

(458,564)

 

 

(607,064)

Corporate

 

 

 

 

 

 

 

 

 

Fair value

 

 

14,304,322 

 

 

5,745,289 

 

 

20,049,611 

Cost or amortized cost

 

 

14,550,153 

 

 

5,892,700 

 

 

20,442,853 

Unrealized loss

 

 

(245,831)

 

 

(147,411)

 

 

(393,242)

Municipal

 

 

 

 

 

 

 

 

 

Fair value

 

 

3,069,720 

 

 

838,980 

 

 

3,908,700 

Cost or amortized cost

 

 

3,100,036 

 

 

869,008 

 

 

3,969,044 

Unrealized loss

 

 

(30,316)

 

 

(30,028)

 

 

(60,344)

Subtotal, fixed income

 

 

 

 

 

 

 

 

 

Fair value

 

 

34,264,899 

 

 

19,869,687 

 

 

54,134,586 

Cost or amortized cost

 

 

34,689,546 

 

 

20,525,340 

 

 

55,214,886 

Unrealized loss

 

 

(424,647)

 

 

(655,653)

 

 

(1,080,300)

Common stock1

 

 

 

 

 

 

 

 

 

Fair value

 

 

8,187,764 

 

 

 

 

 

8,187,764 

Cost or amortized cost

 

 

10,324,066 

 

 

 —

 

 

10,324,066 

Unrealized loss

 

 

(2,136,302)

 

 

 —

 

 

(2,136,302)

Total

 

 

 

 

 

 

 

 

 

Fair value

 

 

42,452,663 

 

 

19,869,687 

 

 

62,322,350 

Cost or amortized cost

 

 

45,013,612 

 

 

20,525,340 

 

 

65,538,952 

Unrealized loss

 

$

(2,560,949)

 

$

(655,653)

 

$

(3,216,602)



1Effective January 1, 2019, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale. Prior periods have not been recast to conform to the current presentation.

As of December 31, 2018, the Company held 200 equity securities that were in unrealized loss positions. Of these 200 securities, none were in an unrealized loss position for 12 consecutive months or longer prior to December 31, 2018.  



The fixed income portfolio contained 31 securities in an unrealized loss position as of September 30, 2019. Of these 31 securities, 19 have been in an unrealized loss position for 12 consecutive months or longer and represent $54,268 in unrealized losses. All fixed income securities in the investment portfolio continue to pay the expected coupon payments under the contractual terms of the securities. Credit-related impairments on fixed income securities that we do not plan to sell, and for which we are not more likely than not to be required to sell, are recognized in net earnings. Any non-credit related impairment is recognized in comprehensive earnings. Based on management’s analysis, the fixed income portfolio is of a high credit quality and it is believed it will recover the amortized cost basis of the fixed income securities. Management monitors the credit quality of the fixed income investments to assess if it is probable that the Company will receive its contractual or estimated cash flows in the form of principal and interest. There were no other-than-temporary impairment losses recognized in net earnings during the first nine months ended September 30, 2019 and no other-than-temporary impairment losses recognized in net earnings for the same period of 2018. For all fixed income securities at a loss at September 30, 2019, management believes it is probable that the Company will receive all contractual payments in the form of principal and interest. In addition, the Company is not required to, nor does it intend to sell these investments prior to recovering the entire amortized cost basis for each security, which may be maturity. The fixed income securities in an unrealized loss position were not other-than-temporarily impaired at September 30, 2019 and December 31, 2018.



UNREALIZED GAINS AND LOSSES ON EQUITY SECURITIES



The portion of net unrealized losses for the three months ended September 30, 2019 for equity securities held as of September 30, 2019 was $7,603. The portion of net unrealized gains for the nine months ended September 30, 2019 for equity securities held as of September 30, 2019 was $1,716,124.



Other Invested Assets



Other invested assets include privately held investments, including membership in the Federal Home Loan Bank of Chicago (FHLBC), which occurred in February 2018, and a promissory note with the option to borrow up to $1,275,000. The Company funded $625,000 on July 30, 2019. The note bears interest at 6.5%, and is amortized over 20 years with a balloon payment due July 30, 2029.  Our investment in FHLBC stock is carried at cost. Due to the nature of our membership in the FHLBC, the carrying amount approximates fair value. As of September 30, 2019, there were no investments pledged as collateral with the FHLBC. There may be investments pledged as collateral with the FHLBC to ensure timely access to the secured lending facility that ownership of FHLBC stock provides. As of and during the nine month periods ending September 30, 2019, there were no outstanding borrowings with the FHLBC.